We are live on ! Find out more
Verition Fund Management

Verition Fund Management Portfolio holdings

AUM $15.4B
1-Year Est. Return 30.69%
This Fund
S&P 500
This Quarter Est. Return
+4.64%
1 Year Est. Return
+30.69%
3 Year Est. Return
+85.73%
5 Year Est. Return
+92.38%
10 Year Est. Return
+282.97%
AUM
$25.5B
AUM Growth
+$1.24B
Cap. Flow
+$105M
Cap. Flow %
0.41%
Top 10 Hldgs %
24.69%
Holding
4,077
New
350
Increased
983
Reduced
1,897
Closed
618

Sector Composition

Rank Sector Weight
1 Technology 11.94%
2 Financials 11.65%
3 Consumer Discretionary 10.18%
4 Industrials 6.61%
5 Healthcare 4.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WHR icon
1051
Whirlpool
WHR
$2.43B
$3.73M 0.01%
51,654
-28,698
-36% -$2.12M
CVSA
1052
Covista Inc
CVSA
$4.25B
$3.72M 0.01%
36,000
-1,400
-4% -$160K
OSCR icon
1053
Oscar Health
OSCR
$9.41B
$3.71M 0.01%
258,000
-108,811
-30% -$1.88M
GDV icon
1054
Gabelli Dividend & Income Trust
GDV
$2.6B
$3.71M 0.01%
133,426
GLQ
1055
Clough Global Equity Fund
GLQ
$152M
$3.7M 0.01%
483,470
+200
+0% +$1.54K
QCOM icon
1056
Qualcomm
QCOM
$155B
$3.7M 0.01%
21,648
-17,127
-44% -$2.94M
CLX icon
1057
CALL
Clorox
CLX
$11.6B
$3.7M 0.01%
36,700
-7,700
-17% -$836K
ADM icon
1058
PUT
Archer Daniels Midland
ADM
$38.2B
$3.69M 0.01%
64,200
-32,700
-34% -$1.95M
SIG icon
1059
Signet Jewelers
SIG
$3.61B
$3.68M 0.01%
44,447
-108,984
-71% -$10.4M
AACB
1060
Artius II Acquisition Inc
AACB
$291M
$3.68M 0.01%
357,357
+301,259
+537% +$3.09M
RPRX icon
1061
Royalty Pharma
RPRX
$25.9B
$3.67M 0.01%
95,068
-206,000
-68% -$7.86M
ADC icon
1062
Agree Realty
ADC
$9.34B
$3.67M 0.01%
50,900
-492
-1% -$36K
UHS icon
1063
Universal Health Services
UHS
$10.2B
$3.65M 0.01%
16,749
+2,652
+19% +$586K
FCNCA icon
1064
First Citizens BancShares
FCNCA
$24.9B
$3.65M 0.01%
1,701
-812
-32% -$1.53M
BTSG icon
1065
BrightSpring Health Services
BTSG
$11.7B
$3.65M 0.01%
97,415
-85,946
-47% -$2.88M
REAL icon
1066
The RealReal
REAL
$1.46B
$3.65M 0.01%
231,102
+10,859
+5% +$142K
TREX icon
1067
Trex
TREX
$4.51B
$3.64M 0.01%
103,890
+72,509
+231% +$2.93M
ESAB icon
1068
ESAB
ESAB
$5.38B
$3.64M 0.01%
32,615
-98,252
-75% -$11.2M
STLD icon
1069
PUT
Steel Dynamics
STLD
$36B
$3.64M 0.01%
21,500
-36,600
-63% -$5.81M
MDT icon
1070
Medtronic
MDT
$109B
$3.64M 0.01%
37,900
+3,558
+10% +$346K
CBOE icon
1071
CALL
Cboe Global Markets
CBOE
$32.5B
$3.64M 0.01%
14,500
-8,100
-36% -$2.01M
TVA
1072
Texas Ventures Acquisition III Corp
TVA
$315M
$3.64M 0.01%
341,591
-108,442
-24% -$1.18M
CMG icon
1073
CALL
Chipotle Mexican Grill
CMG
$47.2B
$3.64M 0.01%
98,300
-49,600
-34% -$1.79M
UNFI icon
1074
United Natural Foods
UNFI
$3.08B
$3.64M 0.01%
108,017
+73,500
+213% +$2.73M
MANH icon
1075
Manhattan Associates
MANH
$11.2B
$3.64M 0.01%
20,982
+4,965
+31% +$908K

Similar funds

Verition Fund Management's Q4 2025 Portfolio in Review

As of Q4 2025, Verition Fund Management held 4,077 positions worth $25.5B, up 5.1% from $24.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Verition Fund Management's Q4 2025 filing shows 350 new, 983 increased, 1,897 reduced and 618 closed positions. Its largest new stake was Alibaba: 342,895 shares worth $50.3M. The largest sale was Eli Lilly, an estimated $223M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 10% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Verition Fund Management's largest Q4 2025 buy was Alibaba: 342,895 shares worth $50.3M.
  • Verition Fund Management added most to Tesla in Q4 2025, an estimated $579M increase.
  • Verition Fund Management's biggest Q4 2025 reduction was Eli Lilly, cutting an estimated $223M.
  • Verition Fund Management fully exited Invesco Senior Loan ETF in Q4 2025, selling an estimated $79.5M.
  • Verition Fund Management's ten largest holdings make up 25% of its $25.5B portfolio in Q4 2025.
  • Verition Fund Management opened 350 new positions and closed 618 in Q4 2025.
  • Verition Fund Management's portfolio value rose 5.1% quarter-over-quarter to $25.5B.

Based on Verition Fund Management's 13F filing for Q4 2025, filed 13 Feb 2026.